27
November
2018
|
17:29
Europe/London

University cancer research facility renamed Oglesby Cancer Research Building to honour enormous contribution of Michael Oglesby

The University of Manchester building for Manchester Cancer Research Centre (MCRC) researchers has been renamed in a ceremony to honour the contribution of Michael Oglesby, his family, and the Oglesby Charitable Trust to cancer research in Manchester.

Michael has been the chair of the MCRC steering board for 12 years and has played a major role in the growth of cancer research in Manchester during that time. It is in recognition of this role that the building will now be known as the Oglesby Cancer Research Building.

The building for MCRC researchers opposite the Christie, opened in 2015 and houses 150 scientists and 100 academic and support staff. The MCRC is an internationally renowned and hugely successful partnership between The Christie, The University of Manchester and Cancer Research UK. The naming ceremony took place on 20 November.

Professor Nic Jones, inaugural Director of the MCRC, said: “This building means an awful lot to me and I am so thrilled that from now on it will be named in Michael’s honour. He was instrumental in getting the project off the ground and in guiding its development through the inevitable ups and downs.

“His tireless support for the Centre and its ambitions has been there right from the start. We started on that journey together not really knowing how far it would take us and sharing that journey has been so inspiring.”

Professor Rob Bristow, MCRC Director, said: “I came to Manchester last year because I saw a unique opportunity. Much of that was down the ethos of collaboration that this building represents, and the ambition shown by Michael and the rest of the MCRC leadership. It is fantastic that we can honour him in this way.”

Michael holds an honorary doctorate from the University, is one of its most generous donors and has made huge contributions in money, time and influence to the University and beyond.

Professor Rob Bristow
I came to Manchester last year because I saw a unique opportunity. Much of that was down the ethos of collaboration that this building represents, and the ambition shown by Michael and the rest of the MCRC leadership. It is fantastic that we can honour him in this way.
Professor Rob Bristow

Michael, who was joined by his family said: “We are very proud to have the Oglesby name associated with this building, which is a landmark building in the city. It makes a statement to the rest of the world about Manchester’s success and ambition in cancer research. But most importantly it tells patients that their first class treatment has cutting edge science behind it, which in turn gives them hope, and that is priceless.”

The Oglesby Charitable Trust has supported many initiatives and projects across the University, but with a considerable focus on cancer. The Trust made a lead gift to the MCRC building and a further gift to the Centre for Cancer Biomarkers. Michael’s visionary philanthropy has also led to establishing a translational patient-centred research group to investigate an unusual type of chronic leukaemia (CMML).

Michael is also playing a leading role in the development of plans for a new world-class cancer research facility which is to be built at The Christie on the site of the Paterson building which suffered devastating fire damage in April 2017 displacing over 300 scientists and support staff.

Located across the road from the Oglesby Cancer Research Building, it will be a major step forward in realising the MCRC’s ambition of becoming one of the world’s top five centres for basic, translational and clinical cancer research.

Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester, said: “Virtually wherever you walk across our campus, if you look closely enough, you’ll find evidence of quite what an impact the Oglesby family has had on the University across a wide range of fields of endeavour. However, the area that Michael’s enthusiasm, commitment and insight has had the greatest impact is cancer research, which makes this naming so appropriate.”

About Michael Oglesby

Michael Oglesby CBE DL LLD DSC founded the Bruntwood Group of companies in 1978 which is now one of the leading commercial property owners and developers in the English regions, owning in excess of 120 buildings in central and south Manchester, Liverpool, Leeds and Birmingham, with a value in excess of £1,000 million.

At the end 2013 Michael relinquished executive responsibility in the company and is now devoting his time to a broad portfolio of principally philanthropic activities covering the arts, civic roles, philanthropy, health and education

He is Chairman of the Oglesby Charitable Trust which has given in excess of £16 million to over 300 charities during the last 20 years. The Trust has a broad portfolio of giving which for many years has included support for both the Christie and The University of Manchester encompassing medical research, contributing to a number of major building projects and arts installations.

Michael is a former High Sheriff and Vice Lord Lieutenant of Greater Manchester and, in the 2011 January Honours List, was awarded the CBE for his services to Industry and Charity.

Cancer

Cancer is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

Share this release